Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
This study is currently recruiting participants.
Verified May 2012 by PsychoGenics Inc.
Study NCT01266174   Information provided by PsychoGenics Inc.

First Received on December 21, 2010.   Last Updated on May 2, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cognitive Impairment
Schizophrenia
Additional conditions recognized in this trial
Cognition Disorders
More general conditions related to this trial
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Eltoprazine
Placebo
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Serotonin Agents
Serotonin Receptor Agonists
Sponsors listed in this trial
PsychoGenics Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services